Genetic research in Psychiatry is viewed by clinicians with both hope and curiosity sometimes mixed with disillusionment. Indeed, in the last 30 years many results have not been confirmed and clinical applications are still missing. However, recent findings suggest that we are at the beginning of a new era. A set of variants within neuroplasticity and inflammation genes have been identified as a valid basis for both bipolar disorder and major depression. Similarly, a set of genes has been identified as a liability factor for response and tolerability to antidepressants and the first clinical applications are already in the market. However, some caution should be applied until definite findings are available.
Genetyka i farmakogenetyka zaburzeÅ nastroju = Genetics and pharmacogenetics of mood disorders / Serretti, Alessandro. - In: PSYCHIATRIA POLSKA. - ISSN 0033-2674. - STAMPA. - 51:2(2017), pp. 197-203. [10.12740/PP/68914]
Genetyka i farmakogenetyka zaburzeÅ nastroju = Genetics and pharmacogenetics of mood disorders
Serretti, Alessandro
2017
Abstract
Genetic research in Psychiatry is viewed by clinicians with both hope and curiosity sometimes mixed with disillusionment. Indeed, in the last 30 years many results have not been confirmed and clinical applications are still missing. However, recent findings suggest that we are at the beginning of a new era. A set of variants within neuroplasticity and inflammation genes have been identified as a valid basis for both bipolar disorder and major depression. Similarly, a set of genes has been identified as a liability factor for response and tolerability to antidepressants and the first clinical applications are already in the market. However, some caution should be applied until definite findings are available.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.